Aurora A Inhibitor I,
1158838-45-9,
2,4-Bisanilinopyrimidine, 10,
N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenyl)amino)-5-fluoropyrimidin-4-yl)amino)benzamide,
TC-S 7010,
N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide,
N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)-phenyl)amino)-5-fluoropyrimidin-4-yl)amino)benzamide,
N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]anilino]-5-fluoropyrimidin-4-yl]amino]benzamide,
AuroraAinhibitorI,
N-(2-Chlorophenyl)-4-[(2-{4-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]anilino}-5-fluoropyrimidin-4-yl)amino]benzamide,
N-(2-chlorophenyl)-4-{[2-({4-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]phenyl}amino)-5-fluoropyrimidin-4-yl]amino}benzamide,
Aurora-A-inhibitor-I,
Aurora Inhibitor, 35,
Aurora A Inhibitor I/,
C31H31ClFN7O2,
MLS006011045,
CHEMBL502124,
GTPL8466,
SCHEMBL15458953,
BDBM31837,
CHEBI:91365,
CTK4A9531,
KS-00001DXT,
DTXSID60657630,
BCPP000376,
HMS3265K21,
HMS3265K22,
HMS3265L21,
HMS3265L22,
HMS3654N08,
BCP02101,
ABP000607,
ANW-58929,
s1451,
ZINC42803194,
AKOS015995069,
BCP9000341,
CS-0011,
compound 10 [PMID: 19402633],
NCGC00346525-01,
NCGC00346525-07,
4CA-0209,
AN-16895,
HY-70061,
SMR004702837,
DB-060777,
TC-147674,
FT-0714298,
SW220199-1,
X7384,
W-5640,
BRD-K53561341-001-01-8,
Benzamide, N-(2-chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]-,
N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]-benzamide,
N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethylpiperazin-1-yl)-2-oxo-ethyl]anilino]-5-fluoro-pyrimidin-4-yl]amino]benzamide,
Compound 10,
D03CRT,
A4126,
A10100,